Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The firm primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Follow-Up Questions
What is the price performance of BWAY stock?
The current price of BWAY is $15.96, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Brainsway Ltd?
Brainsway Ltd belongs to Health Care industry and the sector is Health Care
What is Brainsway Ltd market cap?
Brainsway Ltd's current market cap is $301.6M
Is Brainsway Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Brainsway Ltd, including 3 strong buy, 3 buy, 1 hold, 0 sell, and 3 strong sell
